Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias

समान संसाधन

• Dose Escalation of Lenalidomide in Relapsed or Refractory Acute Leukemias
  द्वारा: Blum, William, और अन्य
  प्रकाशित: (2010)
• Flavopiridol Can Be Safely Administered Using a Pharmacologically Derived Schedule and Demonstrates Activity in Relapsed and Refractory Non-Hodgkin’s Lymphoma
  द्वारा: Jones, Jeffrey A., और अन्य
  प्रकाशित: (2013)
• Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia
  द्वारा: Phelps, Mitch A., और अन्य
  प्रकाशित: (2009)
• Development and validation of a sensitive liquid chromatography/mass spectrometry method for quantitation of flavopiridol in plasma enables accurate estimation of pharmacokinetic parameters with a clinically active dosing schedule
  द्वारा: Phelps, Mitch A,, और अन्य
  प्रकाशित: (2008)
• Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach
  द्वारा: Stephens, Deborah M., और अन्य
  प्रकाशित: (2012)